Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration.
Picca A, Calvani R, Coelho-Junior HJ, Landi F, Bernabei R, Marzetti E. · 2020
Read Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration. by Picca A, Calvani R, Coelho-Junior HJ, Landi F, Bernabei R, Marzetti E. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7466131.txt.
Introduction
Picca and co-authors review how mitochondrial faults, oxidative stress, and brain inflammation intertwine. Oxidative stress reflects a breach in a cell's antioxidant guard. Mitochondria both make reactive oxygen species and suffer from them.
Under stress, parts of mitochondria, including their DNA, can escape the organelle. Freed mitochondrial DNA can act as a danger signal. It binds receptors that spark innate immune inflammation. Such inflammation marks many brain disorders, so these signals may form a shared thread. The review sets the story in Alzheimer's and Parkinson's diseases and in Down syndrome. It explores weak spots in mitochondrial quality control. Those weak spots may yield new drug targets for neurodegeneration.
Catalog record
| CREATOR | Picca A, Calvani R, Coelho-Junior HJ, Landi F, Bernabei R, Marzetti E. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 86 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Mitochondrial Dysfunction, Oxidative Stress, and Neuroinflammation: Intertwined Roads to Neurodegeneration By Anna Picca, Riccardo Calvani, Hélio José Coelho-Junior, Francesco Landi, Roberto Bernabei, Emanuele Marzetti Published in: Antioxidants DOI: 10.3390/antiox9080647 ABSTRACT Abstract Oxidative stress develops as a response to injury and reflects a breach in the cell’s antioxidant capacity. Therefore, the fine-tuning of reactive oxygen species (ROS) generation is crucial for preserving cell’s homeostasis. Mitochondria are a major source and an immediate target of ROS. Under different stimuli, including oxidative stress and impaired quality control, mitochondrial constituents (e.g., mitochondrial DNA, mtDNA) are displaced toward intra- or extracellular compartments. However, the mechanisms responsible for mtDNA unloading remain largely unclear. While shuttling freely within the cell, mtDNA can be delivered into the extracellular compartment via either extrusion of entire nucleoids or the generation and release of extracellular vesicles. Once discarded, mtDNA may act as a damage-associated molecular pattern (DAMP) and trigger an innate immune inflammatory response by binding to danger-signal receptors. Neuroinflammation is associated with a large array of neurological disorders for which mitochondrial DAMPs could represent a common thread supporting disease progression. The exploration of non-canonical pathways involved in mitochondrial quality control and neurodegeneration may unveil novel targets for the development of therapeutic agents. Here, we discuss these processes in the setting of two common neurodegenerative diseases (Alzheimer’s and Parkinson’s disease) and Down syndrome, the most frequent progeroid syndrome. Keywords: Alzheimer’s disease, cytokines, DAMPs, Down syndrome, endo-lysosomal system, extracellular vesicles, mitochondrial DNA, mitochondrial quality control, mitophagy, Parkinson’s disease 1. INTRODUCTION Oxidative stress and neuroinflammation are pathologic signatures of neurodegeneration [1,2]. Cells of innate immunity are a source of reactive oxygen species (ROS) within the central nervous system (CNS), with oxidant overproduction being a candidate mechanism in neuronal damage and loss via neuroinflammation [3,4]. The molecular determinants of immune-mediated oxidative stress and neurodegeneration remain poorly understood. However, microglia activation is considered to be a major contributor [3,5]. Microglial cells are CNS macrophages that ensure homeostasis of the nervous tissue by clearing out damaged neurons and limiting the spread of infections. As a first line of defense against microbes, this macrophage population triggers inflammation via cytokine production and instigates ROS generation [6]. However, a long-standing pro-inflammatory and pro-oxidant environment sustained by persistent microglia activation is detrimental as it may contribute to neurodegeneration. This is particularly relevant in the context of Alzheimer’s (AD) and Parkinson’s disease (PD) [7,8]. Metabolic changes in microglia have also been associated with a state of chronic low-grade inflammation observed during aging (i.e., inflamm-aging) [9,10]. Oxidative stress is also a hallmark of progeroid conditions. For instance, Down syndrome (DS), caused by a genetic imbalance of chromosome 21 which contains genes coding for enzymes implicated in oxidative stress (e.g., Cu/Zn superoxide dismutase, SOD1), is characterized by a breach in antioxidant defenses [11,12]. What is more relevant, people with DS, among other clinical features, show cognitive deficits and are prone to developing AD [13]. Hence, a deeper understanding of the molecular determinants of progeroid conditions may provide relevant insights into the pathophysiology of age-related neurodegenerative conditions as they may share common roots. Mitochondria are a major source of ROS as a byproduct of the electron transport chain (ETC) activity [14]. These organelles are also a direct ROS target [14]. Oxidative stress-related mitochondrial disarrangements have been indicated as contributors to neurodegeneration [15]. Only recently, it has emerged that, apart from their relevance to cellular energy provision and ROS signaling, mitochondria participate in inflammation by triggering a danger signaling response [16,17]. In particular, in response to various stressors, mitochondrial DNA (mtDNA) can be displaced into intra- or extracellular compartments [18]. Albeit the mechanisms whereby mtDNA is unloaded from mitochondria are largely unclear, several lines of evidence indicate that mtDNA can be shuttled toward the extracellular compartment via the generation and release of extracellular vesicles (EVs) [18,19,20,21]. Along with mtDNA and other mitochondrial components, cell-free intact mitochondria have been found in the blood of healthy people [21]. What is more, these organelles show functional competence [21]. Once released, mitochondrial constituents, in particular mtDNA, may act as damage-associated molecular patterns (DAMPs) that can be sensed as non-self molecules and trigger an innate immune inflammatory response by binding to danger signal receptors [16,17]. Further to this, mitochondria take part in a highly interconnected and dynamic network of organelles and structures, including the endoplasmic reticulum, lysosomes, and the actin cytoskeleton [22,23]. Mitochondrial plasticity is also influenced by energy-sensing mediators including insulin, insulin-like growth factor 1 (IGF1), mechanistic target of rapamycin (mTOR), AMP-activated protein kinase (AMPK), and Sirtuins [24]. Metabolic alterations arising from deregulated nutrient sensing have been reported in the setting of neurodegeneration in conjunction with mitochondrial dysfunction and oxidative stress [24]. Indeed, mitochondrial homeostasis relies upon the integrity of intracellular organelle networks, inter-mitochondrial content exchange, and integration of metabolic signaling [22,24]. Via inter-mitochondrial junctions, adjacent organelles coordinate membrane cristae remodeling [25], while mitochondrial fusion allows matrix and intermembrane space content (i.e., proteins, mtDNA, and metabolites) to be mixed between organelles to avoid focal accumulation of damaged constituents [26]. Recently, tubular protrusions, referred to as mitochondrial nanotunnels, have been identified as novel structures enabling mitochondrial interconnections [27]. Via these structures, mitochondria that are immobilized within post-mitotic tissues (e.g., skeletal muscle, myocardium) and limited in their fusion events, may communicate over long distances [27]. Finally, Golgi-derived vesicles have also been shown to participate in mitochondrial dynamics and homeostasis [28]. Neuroinflammation is associated with a large set of neurological disorders for which mitochondrial derived vesicles (MDVs) may represent a common thread supporting disease progression. The analysis of these pathways may help clarify the events linking cell dyshomeostasis with peripheral changes that could even precede neuroinflammation. Indeed, EVs are shuttle systems whereby cells interact or remove unwanted materials [29]. In the setting of failing mitochondrial fidelity pathways, MDVs serve a further layer of mitochondrial quality control (MQC) orchestrated by mitochondrial–lysosomal crosstalk [20]. The clearance of dysfunctional organelles via MDVs involves the release of noxious material that can potentially trigger sterile inflammation. This response is part of innate immunity and operates through the binding and activation of membrane or cytoplasmic pattern recognition receptors (PRRs) (reviewed in [30]). Indeed, mtDNA possesses hypomethylated CpG motifs that are similar to those of bacterial DNA and are recognized by PRRs [30]. In this context, a comprehensive profiling of neuronal-derived DAMPs, including those transported within MDVs, offers the opportunity to shed light on the complex regulatory network governing intracellular homeostasis. This knowledge may also allow deciphering peripheral changes that accompany neurodegeneration. The relevance of EVs in shuttling DAMPs resides in the unique packaging of the information contained, which confers protection of the cargo and delivery of multiple messengers in a paracrine and endocrine fashion. The exploration of these non-canonical pathways arising from mitochondrial dysfunction and contributing to neurodegeneration may unveil novel targets for the development of therapeutics. Here, we discuss these pathways in the setting of two common neurodegenerative diseases (AD and PD) and DS, the most frequent progeroid syndrome. 2. MITOCHONDRIAL QUALITY CONTROL, MTDNA RELEASE, AND INFLAMMATION 2.1. Failing Mitochondrial Quality Control and mtDNA Release A set of MQC processes spanning from mitochondriogenesis to mitochondrial plasticity, autophagy, and mitochondrial unfolded protein response (UPRmt) are in place to safeguard cell and organismal homeostasis [20]. Mitochondrial dynamics rely upon